Does subcutaneous interleukin-1 receptor antagonist reduce inflammation following subarachnoid haemorrhage?

Registry ID

EUCTR2011-001855-35

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Salford Royal NHS Foundation Trust

Start date

2011-07-06

Completion date

2015-10-01

Last update

2026-08-16

Conditions

• Subarachnoid haemorrhage

Summary

What effect does the specific anti-inflammatory drug (IL-1Ra) have on the levels of a specific inflammatory protein (IL-6) in blood between 3-8 days after a brain haemorrhage?

Locations

• , , UK

Related clinical trials

• Current Implementation and Future Options for Stroke Aftercare—An Exploratory, Cross-Sectoral, Questionnaire-Based Study in the Greater Leipzig Area
• Effect of Wearable Sensors on Patient Engagement and Motivation in Post Stroke Rehabilitation
• Does gait training with the Incedo™ improve walking performance and gait parameters in subacute ambulatory patients with stroke-related hemiparesis?
• Pragmatic impairment after stroke and traumatic brain injury: Theoretical implications and empirical evaluation of a novel linguistic assessment
• Does electrostimulation with the Incedo in the supine position improve muscle activity in the affected lower limb as well as walking performance in non-ambulatory patients after stroke?
• Does treadmill-based gait training with the Incedo-system improve walking performance and gait parameters in subacute stroke patients with severe hemiparesis who are unable to walk independently

View on source registry